Close Menu
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

There’s Comfort In Conquering The Past

November 19, 2026

Sudden withdrawal of Trump’s FDA pick left key senator fuming

November 19, 2026

Stock market today: Dow sinks 1,100 points, S&P 500 and Nasdaq tank 2% as Anthropic IPO grabs spotlight

November 19, 2026
Newsward
  • World
  • US
    • Politics
  • Tech
    • Science/Tech
  • Money
    • Business and Market Watch
    • Crypto
    • Career
  • Health
    • Fitness
  • State of Women
  • Opinion
  • Sports
    • NFL
    • MLB
Subscribe
Newsward
Home » Sudden withdrawal of Trump’s FDA pick left key senator fuming
Us

Sudden withdrawal of Trump’s FDA pick left key senator fuming

By November 19, 2026No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
Sudden withdrawal of Trump’s FDA pick left key senator fuming
Share
Facebook Twitter LinkedIn Pinterest Email

Abandonment of FDA Nomination: Dr. Heidi Overton’s Candidacy Withdrawn

In a surprising move late on Tuesday, the White House decided to withdraw Dr. Heidi Overton’s nomination to lead the Food and Drug Administration (FDA). This conclusion came just hours after senior health officials believed she had secured sufficient support from the Senate for her advancement, as reported by several sources familiar with the situation.

Unexpected Withdrawal

Dr. Overton’s team initially learned of the withdrawal through an Axios report, which they believed to be an error. This swift decision caught many senior officials within the Department of Health and Human Services (HHS) off guard and incited frustration among Republican lawmakers, particularly Senator Bill Cassidy, chair of the Senate’s health committee.

Political Dynamics

It appears that internal political dynamics influenced this unexpected withdrawal. Some sources indicated that Secretary of Health and Human Services Robert F. Kennedy Jr. and new White House Chief of Staff Stephen Miller had developed reservations about Dr. Overton over the past few months—despite initial endorsements. Following the decision, Cassidy expressed his displeasure and suggested that Dr. Overton’s nomination had likely garnered the necessary votes for advancement.

Negotiation and Concessions

Leading up to the withdrawal, Dr. Overton’s team had engaged in extensive negotiations, including making concessions to GOP senators like Josh Hawley. Just before the nomination was withdrawn, her team had worked to secure vital commitments that they believed could strengthen her candidacy.

Implications for the FDA

The FDA has been without a permanent commissioner since May, and the sudden withdrawal of Dr. Overton’s nomination raises concerns about the agency’s leadership entering an election year. Current acting commissioner Kyle Diamantas is expected to vacate his role by the end of the year, creating the possibility of prolonged instability within the agency.

Future of the Nomination Process

In the wake of Dr. Overton’s withdrawal, there are no clear indications that the administration has a plan to nominate a replacement swiftly. Some officials fear that without a Republican nominee, confirming a new FDA Commissioner will fall to Democrats once they take control of the Senate in January.

Conflicted Loyalties and Policy Stances

The decision has reignited debates regarding the administration’s healthcare agenda within the GOP. Those aligned with Kennedy have reportedly perceived Dr. Overton as a hindrance to advancing their policies. Overton’s supporters argue that she had been a significant advocate for key initiatives at the White House level, and her withdrawal reflects broader shifts in political priorities.

Looking Ahead

The nomination of Dr. Overton, which had begun with strong backing from Trump’s team, faltered amid increasing scrutiny from both internal and external critics. As the administration prepares to chart a new course, the approach to FDA leadership—and healthcare policy at large—remains uncertain.

As the situation develops, it remains crucial for stakeholders to monitor the implications of this decision on public health policies and FDA operations in the coming months. This event underscores the complexities of political negotiations and the impact they can have on essential health institutions.

Written by CNN’s team. Additional contributions by Sarah Owermohle.

FDA fuming Key Left Pick Senator Sudden Trumps Withdrawal
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleStock market today: Dow sinks 1,100 points, S&P 500 and Nasdaq tank 2% as Anthropic IPO grabs spotlight
Next Article There’s Comfort In Conquering The Past

Related Posts

US zoo staff monitor Fiona the hippo’s rear end for signs of hat she ate | Ohio

November 19, 2026

Army document clarifies Gov. Wes Moore’s medal controversy

November 19, 2026

East Coast storm could become ‘Kyle’ this weekend

November 19, 2026

U.S. Army to detonate unstable explosives in Iowa Friday, potentially sending toxic lead dust into NW Illinois

November 19, 2026

Top Articles

GTA 6 Leak: Cyberleek’s 24-Min Lucia Video [2026]

October 12, 2026

How Novig became the third biggest prediction market site despite launching only months ago

November 14, 2026

How does Iran view shift in US approach after JD Vance ordered away? | US-Israel war on Iran News

November 14, 2026

‘A tremendous step backwards’: US could lose measles elimination status under RFK Jr’s leadership | US news

November 11, 2026

Don't Miss

Technology

There’s Comfort In Conquering The Past

By November 19, 20260

Nostalgia in Gaming: Remakes and Classic Experiences The realm of video gaming often invites us…

Sudden withdrawal of Trump’s FDA pick left key senator fuming

November 19, 2026

Stock market today: Dow sinks 1,100 points, S&P 500 and Nasdaq tank 2% as Anthropic IPO grabs spotlight

November 19, 2026

Danish MPs approve Greenland security pact with US | Denmark

November 19, 2026

Subscribe to Updates

Subscribe to our newsletter and stay updated with the latest news and exclusive offers.

About Us
About Us

NEWSWARD is an independent news and media company covering the economy, politics, international affairs, and a changing world. Through articles, podcasts, video, and candid conversations, we connect major events to their impact on your life, your livelihood, and your future.

Our purpose is simple: help you understand what matters, think critically, and make informed decisions.

See what’s happening now. Know what’s next.

Don't Miss

There’s Comfort In Conquering The Past

November 19, 2026

Sudden withdrawal of Trump’s FDA pick left key senator fuming

November 19, 2026

Stock market today: Dow sinks 1,100 points, S&P 500 and Nasdaq tank 2% as Anthropic IPO grabs spotlight

November 19, 2026
Most Viewed

GTA 6 Leak: Cyberleek’s 24-Min Lucia Video [2026]

October 12, 2026

How Novig became the third biggest prediction market site despite launching only months ago

November 14, 2026

How does Iran view shift in US approach after JD Vance ordered away? | US-Israel war on Iran News

November 14, 2026
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
© 2026 Newsward. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.